Neuland Laboratories Ltd.
NEULANDLAB Share PricePharmaceuticals & Drugs
₹14,449
-10 (-0.1%)
As on September 8, 2025
Exchange Scrips: BSE524558NSENEULANDLABISININE794A01010
Market Cap ₹ 18,539 Cr
P/E Ratio 71.27
Dividend Yield 0.01 %
Performance
Market performance
Open14,395
High14,548
Volumes38,746
Prev14,449
Low14,211
As on2025-09-08
Historical performance
1 Year High18,100
3 Year High18,100
5 Year High18,100
1 Year Low10,190.7
3 Year Low1,196.95
5 Year Low967
Fundamentals
Company Valuation
Market Cap (₹Cr)
18,539
Face Value (₹)
10
P/E Ratio
71.27
Dividend Yield
0.01 %
Investment Returns
1 Year
12%
3 Years
1102.7%
5 Years
1340.9%
10 Years
2345.9%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 14,323.2 | Bullish |
| 10-DMA | 13,828.3 | Bullish |
| 20-DMA | 13,595.2 | Bullish |
| 50-DMA | 13,301 | Bullish |
| 100-DMA | 12,739.86 | Bullish |
| 200-DMA | 13,082.14 | Bullish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 12 | 12 | 11 | 11 | 11 |
| Foreign Investors | 2 | 2 | 2 | 2 | 2 |
| Domestic Investors | 10 | 10 | 9 | 9 | 9 |
| Public Investors | 42407 | 39321 | 39304 | 34556 | 29066 |
| Government | 1 | 1 | 1 | 1 | 1 |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 71.27.
- 3Y Stock Price CAGR of the stock is 128.7.
- The stock has a beta of 1.1.
- In the last financial year, the company had an EBITDA of ₹3438 Million.
- The company generated revenue of ₹14768 Million in the previous financial year.
Neuland Laboratories Ltd.
14449-10 (-0.1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1143153.3
No. of Shares: 79 (Approx)
Performance:14.3%
P/L: ₹143153.3
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent